Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Short-term Investments (2018 - 2025)

Abeona Therapeutics has reported Short-term Investments over the past 10 years, most recently at $113.0 million for Q4 2025.

  • Quarterly results put Short-term Investments at $113.0 million for Q4 2025, up 51.91% from a year ago — trailing twelve months through Dec 2025 was $113.0 million (up 51.91% YoY), and the annual figure for FY2025 was $113.0 million, up 51.91%.
  • Short-term Investments for Q4 2025 was $113.0 million at Abeona Therapeutics, down from $124.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for ABEO hit a ceiling of $124.2 million in Q3 2025 and a floor of $11.0 million in Q1 2022.
  • Median Short-term Investments over the past 5 years was $46.9 million (2023), compared with a mean of $52.8 million.
  • Biggest five-year swings in Short-term Investments: plummeted 85.34% in 2021 and later soared 294.42% in 2023.
  • Abeona Therapeutics' Short-term Investments stood at $12.1 million in 2021, then soared by 213.85% to $37.9 million in 2022, then decreased by 0.47% to $37.8 million in 2023, then surged by 96.97% to $74.4 million in 2024, then soared by 51.91% to $113.0 million in 2025.
  • The last three reported values for Short-term Investments were $113.0 million (Q4 2025), $124.2 million (Q3 2025), and $62.0 million (Q2 2025) per Business Quant data.